关于中西医结合心血管病临床试验若干问题的意见

发布时间:2018-05-25 03:40

  本文选题:临床试验 + 中西医结合治疗 ; 参考:《中国中西医结合杂志》2010年10期


【摘要】:发展中的医学应当具有两个重要的特点:创新性和可实践性。在我国中医和西医两种治疗途径并存的情况下,如何结合中医和西医各自的优势,做到真正提高现实世界中疾病的防治效果,最能体现这两个特点。创新,是指要解决两者联用中不可避免地要遇到的许多新问题;可实践,是指这种结合最终必须有助于解决临床实践中最需要解决的问题。临床试验是验证这些问题是否得到解决的金标准。临床试验进入我国的时间并不长,但已经逐渐为我国临床医师所认识和接受,也受到中西医结合临床工作者的极大关注,近年来已有不少临床试验的结果得到发表,有些研究也得到国际学界的认可。本期发表的《关于中西医结合心血管病临床试验若干问题的意见》在回顾既往经验和教训的基础上,对我国中西医结合心血管病临床试验的目的、设计、实施和应用等方面提出建议,不仅强调临床试验的科学性要求,而且强调从临床需求出发立题,从一开始就考虑到试验结果的可实践性。这是因为中西医结合临床试验不是简单的单一药物疗效考核,而是旨在探索已经用于临床的两种治疗途径的最佳结合方式,或是确定最佳的中西医结合治疗方案。因此,本文不仅对心血管专业,而且对其他专业的中西医结合临床试验也有一定的参考价值。
[Abstract]:Developing medicine should have two important characteristics: innovation and practicability. In the case of the coexistence of two therapeutic approaches of Chinese medicine and western medicine, how to combine the advantages of traditional Chinese medicine and western medicine to truly improve the effect of disease prevention and treatment in the real world can best reflect these two characteristics. Innovation is to solve many new problems that will inevitably be encountered in the combination of the two, and practicability means that this combination must ultimately help to solve the problems that need to be solved most in clinical practice. Clinical trials are the gold standard for verifying that these problems are resolved. Clinical trials have not been in our country for a long time, but they have been gradually recognized and accepted by Chinese clinicians, and have been greatly concerned by the clinical workers of integrated Chinese and western medicine. In recent years, the results of many clinical trials have been published. Some studies have also been recognized by the international academic community. In this issue, "opinions on some problems in the Clinical trial of Integrated Chinese and Western Medicine on Cardiovascular Diseases", on the basis of reviewing past experiences and lessons, the purpose of clinical trials of integrated traditional Chinese and western medicine on cardiovascular diseases in China is designed. Some suggestions are put forward in the aspects of implementation and application, which not only emphasize the scientific requirements of clinical trials, but also emphasize the construction of problems from the point of view of clinical needs, and consider the practicability of the results from the beginning. This is because the clinical trial of integrated traditional Chinese and western medicine is not a simple evaluation of the efficacy of a single drug, but aimed at exploring the best combination of two therapeutic approaches that have already been used in clinical practice, or to determine the best combination of traditional Chinese and western medicine. Therefore, this article not only for cardiovascular specialty, but also for other professional integrated Chinese and western medicine clinical trials also have certain reference value.
【作者单位】: 中国中西医结合学会心血管病专业委员会;
【分类号】:R54

【相似文献】

相关期刊论文 前10条

1 常波;单丽沈;王云宁;冯军;单丹妮;刘春峰;;中西医结合治疗功能性复发性腹痛疗效分析[J];大连医科大学学报;2009年03期

2 ;国内[J];中国处方药;2010年08期

3 陈浩;史大卓;;近年临床试验及指南对中西医结合治疗冠心病的启示[J];中西医结合心脑血管病杂志;2009年04期

4 范维琥;戴瑞鸿;;中西医结合治疗冠心病的创新之路[J];上海医药;2010年01期

5 胡大一;运用循证医学的新证据指导心血管疾病防治实践[J];中华医学信息导报;2005年22期

6 黄汉超;周凤娇;陈宏s,

本文编号:1931942


资料下载
论文发表

本文链接:https://www.wllwen.com/yixuelunwen/zhxiyjh/1931942.html


Copyright(c)文论论文网All Rights Reserved | 网站地图 |

版权申明:资料由用户d16d3***提供,本站仅收录摘要或目录,作者需要删除请E-mail邮箱bigeng88@qq.com